近期论文

查看导师最新文章 （温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

Marshall, L., Oguejiofor, W., Price, R. and Shur, J., 2016. Investigation of the enhanced antimicrobial activity of combination dry powder inhaler formulations of lactoferrin. International Journal of Pharmaceutics Shur, J., Price, R., Lewis, D., Young, P. M., Woollam, G., Singh, D. and Edge, S., 2016. From single excipients to dual excipient platforms in dry powder inhaler products. International Journal of Pharmaceutics Box, K. J., Comer, J., Taylor, R., Karki, S., Ruiz, R., Price, R. and Fotaki, N., 2016. Small scale assays for studying dissolution of pharmaceutical cocrystals for oral administration. AAPS PharmSciTech, 17 (2), pp. 245-251. Shur, J., Saluja, B., Lee, S., Tibbatts, J. and Price, R., 2015. Effect of device design and formulation on the in vitro comparability for multi-unit dose dry powder inhalers. AAPS Journal, 17 (5), pp. 1105-1116. Kinnunen, H., Hebbink, G., Peters, H., Huck, D., Makein, L. and Price, R., 2015. Extrinsic lactose fines improve dry powder inhaler formulation performance of a cohesive batch of budesonide via agglomerate formation and consequential co-deposition. International Journal of Pharmaceutics, 478 (1), pp. 53-59. Mencarelli, G., Saluja, B., Price, R. and Fotaki, N., 2015. Novel Deposition and In Vitro Dissolution Model for Orally Inhaled Drug Products. In: AAPS Annual Meeting, 2015, 2015-10-25 - 2015-10-29. Depasquale, R., Lee, S. L., Saluja, B., Shur, J. and Price, R., 2014. The influence of secondary processing on the structural relaxation dynamics of fluticasone propionate. AAPS PharmSciTech, 16 (3), pp. 589-600. Kinnunen, H., Hebbink, G., Peters, H., Shur, J. and Price, R., 2014. An Investigation into the Effect of Fine Lactose Particles on the Fluidization Behaviour and Aerosolization Performance of Carrier-Based Dry Powder Inhaler Formulations. AAPS PharmSciTech, 15 (4), pp. 898-909. Kinnunen, H., Hebbink, G., Peters, H., Shur, J. and Price, R., 2014. Defining the critical material attributes of lactose monohydrate in carrier based dry powder inhaler formulations using artificial neural networks. AAPS PharmSciTech, 15 (4), pp. 1009-1020. Tomaszewska, I., Karki, S., Shur, J., Price, R. and Fotaki, N., 2013. Pharmaceutical characterisation and evaluation of cocrystals:importance of in vitro dissolution conditions and type of coformer. International Journal of Pharmaceutics, 453 (2), pp. 380-388. Shur, J., Pitchayajittipong, C., Rogueda, P. and Price, R., 2013. Effect of processing history on the surface interfacial properties of budesonide in carrier-based dry-powder inhalers. Therapeutic Delivery, 4 (8), pp. 925-937. Fotaki, N., Box, K., Comer, J., Mole, J., Taylor, R., Karki, S. and Price, R., 2013. Dissolution and precipitation studies of carbamazepine cocrystals with small scale assays. In: 2013 AAPS Annual Meeting and Exposition, 2013-11-10 - 2013-11-14, Henry B. Gonzalez Convention Center. Shur, J., Lee, S., Adams, W., Lionberger, R., Tibbatts, J. and Price, R., 2012. Effect of device design on the in vitro performance and comparability for capsule-based dry powder inhalers. AAPS Journal, 14 (4), pp. 667-676. Shur, J., Kubavat, H. A., Ruecroft, G., Hipkiss, D. and Price, R., 2012. Influence of crystal form of ipratropium bromide on micronisation and aerosolisation behaviour in dry powder inhaler formulations. Journal of Pharmacy and Pharmacology, 64 (9), pp. 1326-1336. Kubavat, H. A., Shur, J., Ruecroft, G., Hipkiss, D. and Price, R., 2012. Influence of primary crystallisation conditions on the mechanical and interfacial properties of micronised budesonide for dry powder inhalation. International Journal of Pharmaceutics, 430 (1-2), pp. 26-33. Kubavat, H. A., Shur, J., Ruecroft, G., Hipkiss, D. and Price, R., 2012. Investigation into the influence of primary crystallization conditions on the mechanical properties and secondary processing behaviour of fluticasone propionate for carrier based dry powder inhaler formulations. Pharmaceutical Research, 29 (4), pp. 994-1006. Shur, J. and Price, R., 2012. Advanced microscopy techniques to assess solid-state properties of inhalation medicines. Advanced Drug Delivery Reviews, 64 (4), pp. 369-382. de Boer, A. H., Chan, H. K. and Price, R., 2012. A critical view on lactose-based drug formulation and device studies for dry powder inhalation: Which are relevant and what interactions to expect? Advanced Drug Delivery Reviews, 64 (3), pp. 257-274. Rogueda, P. G. A., Price, R., Smith, T., Young, P. M. and Traini, D., 2011. Particle synergy and aerosol performance in non-aqueous liquid of two combinations metered dose inhalation formulations: An AFM and Raman investigation. Journal of Colloid and Interface Science, 361 (2), pp. 649-655. Ireland, A. J., Wilson, A. A., Blythe, L., Johnston, N. J., Price, R. and Sandy, J. R., 2011. Particulate production during orthodontic production laboratory procedures. Journal of Exposure Science and Environmental Epidemiology, 21 (5), pp. 536-540.